Insulet Corp. (PODD)

76.73
0.02 0.03
NASDAQ : Health Technology
Prev Close 76.75
Open 76.25
Day Low/High 75.84 / 77.40
52 Wk Low/High 38.43 / 78.65
Volume 209.34K
Avg Volume 486.90K
Exchange NASDAQ
Shares Outstanding 58.19M
Market Cap 4.28B
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that the...

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 36th Annual J.

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 29th Annual Piper Jaffray...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the Jefferies 2017 London...

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/31/2017 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 10.90 "days to cover" versus the median component at 5.18. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its intention to...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company) the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), is recognizing...

Robbins Arroyo LLP: Insulet Corporation (PODD) Misled Shareholders According To A Shareholder Derivative Lawsuit

Robbins Arroyo LLP: Insulet Corporation (PODD) Misled Shareholders According To A Shareholder Derivative Lawsuit

Shareholder rights law firm Robbins Arroyo LLP announces that a shareholder derivative complaint was filed on behalf of Insulet Corporation (NasdaqGS: PODD).

Insulet And Dexcom Partner To Offer Choices For Animas Users

Insulet And Dexcom Partner To Offer Choices For Animas Users

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company) the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), is partnering with...

Insulet Offers Welcome Program For Animas® Users To Try Omnipod® Insulin Management System At Zero Cost

Insulet Offers Welcome Program For Animas® Users To Try Omnipod® Insulin Management System At Zero Cost

Insulet Corporation's (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), is offering...

Insulet Corporation To Announce Third Quarter 2017 Financial Results On November 2, 2017

Insulet Corporation To Announce Third Quarter 2017 Financial Results On November 2, 2017

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), will host a groundbreaking...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today presented real-world...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced the appointments of Michael R.

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/14/2017 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 11.40 "days to cover" versus the median component at 6.16. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Insulet Reports Second Quarter 2017 Financial Results

Insulet Reports Second Quarter 2017 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced several...

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced plans to assume, on July...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Insulet Stock Sees Short Interest Decline 10%

The most recent short interest data has been released for the 06/15/2017 settlement date, which shows a 432,738 share decrease in total short interest for Insulet Corp , to 3,844,616, a decrease of 10.12% since 05/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Http://www.forbes.com

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced additional...

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it will present...

TheStreet Quant Rating: C- (Hold)